Skip to Main Content
An official website of the United States government

Approved Projects

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Reset
Showing Most Recent
1001-1020 of 2638
Name Principal Investigator Institution Study Date Approved Project ID
Etiologic Studies: Overall Design of Study (Risk Factors for Screen Detected Adenoma) Richard Hayes NCI, DCEG, OEEB PLCO Jul 1, 2006 2006-0126
Evaluate Artera’s Deep Learning clinical-histologic system as a prognostic classifier for colorectal cancer patients Erin Stewart Artera Inc. PLCO Aug 12, 2025 PLCOI-1961
Evaluate Artera’s Deep Learning clinical-histologic system as a prognostic classifier for lung cancer patients Erin Stewart Artera Inc NLST May 30, 2023 NLST-1060
Evaluate Artera’s Deep Learning clinical-histologic system as a prognostic classifier for lung cancer patients Erin Stewart Artera PLCO May 30, 2023 PLCOI-1229
Evaluate performance of the PreciseDx AI-digital LDT Breast assay to predict breast cancer recurrence using clinical data and H&E images from study patients Michael Donovan University of Miami PLCO Mar 9, 2021 PLCOI-741
Evaluate the impact of ovarian cancer interventions for primary prevention, screening and treatment Iakovos Toumazis The University of Texas MD Anderson Cancer Center PLCO Nov 17, 2020 PLCO-689
Evaluating a multi-biomarker panel for the early detection of ovarian cancer Maxwell Akonde University of South Carolina PLCO Apr 8, 2022 PLCO-966
Evaluating Body Mass Index with total and cause-specific mortality by age groups Zheng Guo Vanderbilt University Medical Center PLCO Jan 10, 2025 PLCO-1783
Evaluating cancer mortality in the National Lung Screening Trial Chiung-Yu Huang Johns Hopkins University NLST Apr 18, 2014 NLST-69
Evaluating circulating immunologic markers in the development of multiple myeloma Jonathan Hofmann NCI PLCO Mar 16, 2018 PLCO-355
Evaluating comorbidities and life expectancy in patients undergoing LDCT screening in the real world setting Jonathan Iaccarino Boston University Medical Campus NLST May 19, 2017 NLST-309
Evaluating existing data on circulating inflammatory markers in relation to history of benign gynecologic pathology and history of oral contraceptive use. Lauren King NCI-DCEG PLCO Jan 30, 2020 PLCO-576
Evaluating genetic, clinical, and environmental risk factors for second primary lung cancer Summer Han Stanford University NLST Apr 13, 2019 NLST-498
Evaluating genetic, clinical, and environmental risk factors for second primary lung cancer Summer Han Stanford University PLCO Nov 13, 2018 PLCO-423
Evaluating key determinants for the risk of second primary lung cancer among bladder cancer survivors using population-based screening trial data from the PLCO Summer Han Stanford University PLCO Jan 5, 2022 PLCO-886
Evaluating key determinants for the risk of second primary lung cancer among breast and colorectal cancer survivors using population-based screening trial data from the PLCO Summer Han Stanford University PLCO Oct 27, 2020 PLCO-683
Evaluating long term outcomes and over diagnosis in lung cancer screening using the NLST data Dongfeng Wu University of Louisville NLST May 16, 2014 NLST-73
Evaluating long term outcomes and over diagnosis in lung cancer screening using the PLCO data Dongfeng Wu University of Louisville PLCO May 21, 2014 PLCO-86
Evaluating lung cancer screening by competing mortality Rebecca Landy American Cancer Society NLST Jan 29, 2026 NLST-1496
Evaluating Multi-trait PRS Methods on Cancer Phenotypes in PLCO Phillip Kraft National Cancer Institute PLCO Dec 16, 2025 PLCO-2004